Tulane University — New Orleans, Louisiana

Public research footprint of Tulane University, compiled from the ClinicalTrials.gov public registry.

853

Registered studies

149

Active

Recruiting now

563

Completed

111

Stopped or withdrawn

Most-studied conditions

Acute Lymphoblastic Leukemia · Chromophobe Renal Cell Carcinoma · Sarcomatoid Renal Cell Carcinoma · Recurrent Ovarian Carcinoma

Recently updated registry entries

NCT06012240 — A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and… (Recruiting)
NCT01272037 — Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in… (Active Not Recruiting)
NCT01503632 — Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Tulane University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.